ArticleNature communications2025
Sequential Organic Ligand Modifications to Dedicatedly Restructure Grain Boundary and Surface of Perovskites.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Intermediate-Site Anchoring Ligands Enable Robust Nonlayered Interfacial Passivation for Efficient and Stable Air-Processed Perovskite Solar Cells.Advanced materials (Deerfield Beach, Fla.) · 2026Article
- Terahertz Time-Domain Spectroscopy as a Defect Fingerprinting Tool for Halide Perovskite Solar Cells: Toward a Universal Framework.Nanomaterials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The durability of perovskite solar cells (PSCs) is substantially limited by defects and imperfect structures at grain boundaries (GBs) and grain surfaces (GSs) of perovskites, where common single-step ligand passivation struggles due to ligand heterogeneous distributions and distinct chemical environments. Herein, we demonstrate a two-step sequential dedicated-ligand (TSS-DL) strategy that selectively targets GBs and GSs through spatially resolved interactions of the dedicated ligands. We identified two classes of dedicated ligands, including Ligand X, notably 2,2-difluoroacetamide bromide (DFABr) for GBs to restructure them into stable 2D perovskites and suppress defects, and Ligand Y, featuring 4-aminopiperidinium dibromide (4APPBr
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.